Porcine Reproductive & Respiratory Syndrome roadmap:
Vaccines
Roadmap for development of a candidate vaccine for PRRSV
Download PRRSV Vaccine Roadmap8
Attenuated organisms
Dependencies
- 13 Identity of virulence factors
- 14 Identity of immunomodulators
- 15 Host responses to natural infection
Next steps
- 3 Rationally attenuated candidates
- 3A Safety
- 3B Delivery route
- 3C Delivery platform
- 3D Efficacy in challenge model
The generation of rationally attenuated genetically modified PRRSV
Research Question
- To generate organisms that are less virulent in terms of pathological changes that they cause and/or their ability to modulate the host’s immune responses – rationally attenuated vaccine
Research Gaps and Challenges
- That the organisms are stable and can be produced in cell culture
- That they still generate a protective response
Solution Routes
- Generation of infectious cDNA clones
- Generation and characterisation of a range of rationally attenuated organisms (using codon pair deoptimization)
- Immune response to the attenuated organisms
Dependencies
- Identity of Virulence factors and their genes
- Identity of immunomodulators
Projects
What activities are planned or underway?
Generating antibodies broadly neutralising porcine reproductive and respiratory syndrome virus (PRRSV)
Planned Completion date 31/12/2025
Source Countries:
Denmark
Identification of interferon stimulated genes that control Toxoplasma in pig macrophages
Planned Completion date 01/03/2026
Source Countries:
United Kingdom